Trademark: 98342069
Word
HARBOR
Status
Pending
Status Code
641
Status Date
Wednesday, August 7, 2024
Serial Number
98342069
Mark Type
4
Filing Date
Thursday, January 4, 2024

Trademark Owner History

Classifications
5 Therapeutic pharmaceuticals in the nature of oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
42 Providing medical and scientific research information in the fields of pharmaceuticals and biotechnology

Trademark Events
Apr 21, 2024
New Application Office Supplied Data Entered
Jul 31, 2024
Assigned To Examiner
Aug 7, 2024
Notification Of Non-Final Action E-Mailed
Aug 7, 2024
Non-Final Action E-Mailed
Aug 7, 2024
Non-Final Action E-Mailed
Aug 7, 2024
Notification Of Non-Final Action E-Mailed
Aug 7, 2024
Non-Final Action Written
Aug 7, 2024
Non-Final Action Written
Jan 4, 2024
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24